198 related articles for article (PubMed ID: 18203662)
1. T-type Ca2+ channels as therapeutic targets in the nervous system.
Shin HS; Cheong EJ; Choi S; Lee J; Na HS
Curr Opin Pharmacol; 2008 Feb; 8(1):33-41. PubMed ID: 18203662
[TBL] [Abstract][Full Text] [Related]
2. T-type Ca2+ channels in normal and abnormal brain functions.
Cheong E; Shin HS
Physiol Rev; 2013 Jul; 93(3):961-92. PubMed ID: 23899559
[TBL] [Abstract][Full Text] [Related]
3. Linking calcium-channel isoforms to potential therapies.
Belardetti F; Zamponi GW
Curr Opin Investig Drugs; 2008 Jul; 9(7):707-15. PubMed ID: 18600576
[TBL] [Abstract][Full Text] [Related]
4. Targeting Ca2+ channels to treat pain: T-type versus N-type.
Altier C; Zamponi GW
Trends Pharmacol Sci; 2004 Sep; 25(9):465-70. PubMed ID: 15559248
[TBL] [Abstract][Full Text] [Related]
5. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
6. T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites.
Cueni L; Canepari M; Luján R; Emmenegger Y; Watanabe M; Bond CT; Franken P; Adelman JP; Lüthi A
Nat Neurosci; 2008 Jun; 11(6):683-92. PubMed ID: 18488023
[TBL] [Abstract][Full Text] [Related]
7. Regulation of neuronal T-type calcium channels.
Iftinca MC; Zamponi GW
Trends Pharmacol Sci; 2009 Jan; 30(1):32-40. PubMed ID: 19042038
[TBL] [Abstract][Full Text] [Related]
8. T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin.
Rimoli MG; Russo E; Cataldi M; Citraro R; Ambrosino P; Melisi D; Curcio A; De Lucia S; Patrignani P; De Sarro G; Abignente E
Neuropharmacology; 2009 Mar; 56(3):637-46. PubMed ID: 19071141
[TBL] [Abstract][Full Text] [Related]
9. The role of peripheral T-type calcium channels in pain transmission.
Jevtovic-Todorovic V; Todorovic SM
Cell Calcium; 2006 Aug; 40(2):197-203. PubMed ID: 16777222
[TBL] [Abstract][Full Text] [Related]
10. T-type Ca2+ channels and absence epilepsy.
Shin HS
Cell Calcium; 2006 Aug; 40(2):191-6. PubMed ID: 16777220
[TBL] [Abstract][Full Text] [Related]
11. Calcium channels in chromaffin cells: focus on L and T types.
Marcantoni A; Carabelli V; Comunanza V; Hoddah H; Carbone E
Acta Physiol (Oxf); 2008 Feb; 192(2):233-46. PubMed ID: 18021322
[TBL] [Abstract][Full Text] [Related]
12. Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
Chemin J; Traboulsie A; Lory P
Cell Calcium; 2006 Aug; 40(2):121-34. PubMed ID: 16797700
[TBL] [Abstract][Full Text] [Related]
13. Hyperalgesia induced by spinal and peripheral hydrogen sulfide: evidence for involvement of Cav3.2 T-type calcium channels.
Maeda Y; Aoki Y; Sekiguchi F; Matsunami M; Takahashi T; Nishikawa H; Kawabata A
Pain; 2009 Mar; 142(1-2):127-32. PubMed ID: 19167819
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels.
Nagasawa K; Tarui T; Yoshida S; Sekiguchi F; Matsunami M; Ohi A; Fukami K; Ichida S; Nishikawa H; Kawabata A
J Neurochem; 2009 Feb; 108(3):676-84. PubMed ID: 19054275
[TBL] [Abstract][Full Text] [Related]
15. T-type calcium channels inhibitors: a patent review.
Giordanetto F; Knerr L; Wållberg A
Expert Opin Ther Pat; 2011 Jan; 21(1):85-101. PubMed ID: 21087200
[TBL] [Abstract][Full Text] [Related]
16. [Molecular effects of new calcium antagonists: is the principle of parcimony out of place?].
Richard S; Virsolvy A; Fort A
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):166-73. PubMed ID: 18565491
[TBL] [Abstract][Full Text] [Related]
17. [Pathological changes of potential-activated calcium channels in sensory neurons].
Kostiuk OP; Pinchenko VO; Kostiuk PH
Fiziol Zh (1994); 2008; 54(3):81-91. PubMed ID: 18763584
[TBL] [Abstract][Full Text] [Related]
18. T-type calcium channels and thalamocortical rhythms in sleep: a perspective from studies of T-type calcium channel knockout mice.
Lee J; Shin HS
CNS Neurol Disord Drug Targets; 2007 Feb; 6(1):63-9. PubMed ID: 17305554
[TBL] [Abstract][Full Text] [Related]
19. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels.
Mangoni ME; Traboulsie A; Leoni AL; Couette B; Marger L; Le Quang K; Kupfer E; Cohen-Solal A; Vilar J; Shin HS; Escande D; Charpentier F; Nargeot J; Lory P
Circ Res; 2006 Jun; 98(11):1422-30. PubMed ID: 16690884
[TBL] [Abstract][Full Text] [Related]
20. Positive allosteric interaction of structurally diverse T-type calcium channel antagonists.
Uebele VN; Nuss CE; Fox SV; Garson SL; Cristescu R; Doran SM; Kraus RL; Santarelli VP; Li Y; Barrow JC; Yang ZQ; Schlegel KA; Rittle KE; Reger TS; Bednar RA; Lemaire W; Mullen FA; Ballard JE; Tang C; Dai G; McManus OB; Koblan KS; Renger JJ
Cell Biochem Biophys; 2009; 55(2):81-93. PubMed ID: 19582593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
